In 2023, Japan had the highest mortality for Pancreas Malignant Neoplasms at 32.4 deaths per hundred thousand persons, showcasing a year-on-year increase of 2.96%. Finland and Germany followed, each demonstrating relatively modest increases of 1.08% and 1.15%, respectively. Countries like Estonia and Argentina showed a decrease year-on-year, highlighting unique regional healthcare dynamics. South Korea, Iceland, and Peru exhibited the highest percentage increases year-on-year, indicating emerging health challenges. Conversely, countries in South America, including Brazil, Chile, Peru, and Mexico, maintained much lower mortality rates, reflecting either underdiagnosis or other public health interventions.
Future trends to watch include the potential rising mortality rates in regions like South Korea and Iceland, and a vigilant eye on Japan's persistently high figures. Health policy improvements focusing on early diagnosis and management of pancreatic cancer will be crucial for curbing these trends globally.
Top countries in Pancreas Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Deaths) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 32.4 | 2023 | +2.53% | +2.96% | View data |
| 2 | 2 Finland | 24.8 | 2023 | +2.06% | +1.08% | View data |
| 3 | 3 Germany | 23.4 | 2023 | +0.43% | +1.15% | View data |
| 4 | 4 Hungary | 23 | 2023 | +1.32% | +0.89% | View data |
| 5 | 5 Czech Republic | 22.5 | 2023 | +1.35% | +2.08% | View data |
| 6 | 6 Latvia | 22.4 | 2023 | +1.82% | +1.79% | View data |
| 7 | 7 Austria | 21.7 | 2023 | +1.4% | +1.14% | View data |
| 8 | 8 Estonia | 21 | 2023 | +1.45% | -1.28% | View data |
| 9 | 9 Slovenia | 20.7 | 2023 | +1.97% | +1.62% | View data |
| 10 | 10 Denmark | 20.5 | 2023 | +1.99% | +2.19% | View data |
